Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prior clinically diagnosed human papillomavirus infection and risk of esophageal cancer.

Scientific reports·2026

Same author

Seasonal variation in climate, air pollution, and the incidence of benign paroxysmal positional vertigo.

Scientific reports·2026

Same author

Increased prevalence of hearing loss and tinnitus in patients with retinal vein occlusion.

Scientific reports·2026

Same author

Association of alzheimer's disease with prior allergic rhinitis.

Scientific reports·2026

Same author

Associations of chronic rhinosinusitis and allergic rhinitis with tinnitus.

Scientific reports·2026

Same author

A population-based study on the association of peripheral vestibular disorder with allergic rhinitis.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2025

Search research articles

Related Experiment Video

Updated: May 24, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Association between viral hepatitis and erectile dysfunction: a population-based case-control analysis.

Shiu-Dong Chung¹, Joseph J Keller, Yu-Chih Liang

¹Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, Ban Ciao, Taipei, Taiwan.

The Journal of Sexual Medicine

|March 2, 2012

Summary

This summary is machine-generated.

Erectile dysfunction (ED) is linked to a history of viral hepatitis, particularly hepatitis B and C coinfection. This population-based study highlights a significant association, even after accounting for other health conditions.

Related Experiment Videos

Last Updated: May 24, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

Hepatology
Urology
Public Health

Background:

Chronic liver diseases are associated with hypogonadism and erectile dysfunction (ED).
Studies on the link between ED and viral hepatitis are limited.
Viral hepatitis may be an underrecognized contributor to ED.

Purpose of the Study:

To investigate the association between prior viral hepatitis diagnosis and ED.
Utilize a large population-based dataset in Taiwan for a case-control study.
Quantify the risk of ED in patients with a history of viral hepatitis.

Main Methods:

A case-control study design was employed.
Identified 6,429 patients with ED (cases) and 32,145 controls.
Conditional logistic regression analyzed the odds of prior viral hepatitis diagnosis.

Main Results:

Viral hepatitis was diagnosed in 14.0% of ED cases versus 9.4% of controls.
ED cases had significantly higher odds of prior viral hepatitis (OR=1.51).
Hepatitis B and C coinfection showed a stronger association with ED (OR=1.84).

Conclusions:

ED is significantly associated with a history of viral hepatitis.
Hepatitis B and C coinfection presents a particularly elevated risk for ED.
Viral hepatitis should be considered in the evaluation of ED patients.